Xact Kapitalforvaltning’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Xact Kapitalforvaltning's GILD Position: Q1 2020 in Review
Xact Kapitalforvaltning increased its Gilead Sciences (GILD) stake by 1.8% in Q1 2020, buying an estimated $341K and bringing the position to 281,616 shares worth $21.1M. The position accounts for 0.45% of the portfolio, ranked #48.
Xact Kapitalforvaltning first reported a position in GILD in Q3 2016 and has held it in 15 quarters since. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.
- Xact Kapitalforvaltning held 281,616 shares of Gilead Sciences worth $21.1M as of Q1 2020.
- Xact Kapitalforvaltning bought 4,932 Gilead Sciences shares in Q1 2020, an estimated $341K.
- Gilead Sciences made up 0.45% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #48 holding.
- Xact Kapitalforvaltning first reported a position in Gilead Sciences in Q3 2016 and has held it in 15 quarters since.
- 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.
Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.